Latest Partnerships News

Strike Energy has announced a strategic placement and share purchase plan raising up to A$103 million to advance its core Perth Basin gas projects, backed by a significant investment from Carnarvon Energy. This funding underpins key developments targeting first production by late 2026 and a final investment decision for West Erregulla.

Carnarvon Energy is set to invest up to A$88 million in Strike Energy through a two-tranche equity placement, positioning itself as Strike’s largest shareholder. This strategic move aims to accelerate development of Strike’s key Perth Basin assets, with production milestones targeted by 2026.

Carnarvon Energy is set to acquire up to a 19.9% stake in Strike Energy through an $89 million investment, positioning itself to benefit from Strike’s expanding gas portfolio in Western Australia.

Carnarvon Energy is set to become Strike Energy’s largest shareholder through a strategic A$88 million equity placement, underpinning key project developments in Western Australia’s Perth Basin. Strike also launches a Share Purchase Plan to raise additional funds, aiming to accelerate production milestones by 2026.

Microba Life Sciences reports strong Q4 FY25 growth driven by record microbiome test sales and clinician adoption in Australia and the UK, while advancing its therapeutics pipeline and targeting regional break-even in FY26.

Microba Life Sciences reports record Q4 FY25 microbiome test sales in Australia and the UK, underpinned by landmark clinical studies and a $14.5 million capital raise. The company is transitioning away from legacy products to focus on high-value diagnostics, positioning for sustained growth in FY26.

PPK Group’s majority-owned PowerPlus Energy launches two Clean Energy Council-approved batteries eligible for the Australian Government’s new Cheaper Home Batteries Program rebates, positioning itself to capture a significant share of the emerging residential energy storage market.

Praemium Limited reports a 2.2% increase in funds under administration for Q4 FY25, driven by strong gains in Spectrum and SMA platforms, alongside operational upgrades including AI-driven initiatives. However, OneVue platform experiences a significant decline.

Genetic Signatures reported steady quarterly sales of $4.4 million, reflecting seasonal demand in Australia, while restructuring its US operations to accelerate growth. A new US contract and strategic partnerships signal potential for future expansion.

Genetic Signatures has formed a strategic partnership with Tecan and Repado to develop a fully automated, scalable infectious disease testing platform integrating advanced automation, compliant software, and proprietary assays.

OMG Group Limited has reported a remarkable 253% increase in quarterly cash receipts for Q4 FY25, driving annual revenues up 63% to $4.13 million and positioning the company for further growth in FY26.

Hazer Group has forged a strategic alliance with engineering giant KBR to fast-track commercial deployment of its methane pyrolysis technology, supported by a $10.7 million capital raise and promising project developments in Japan.